The modulation of NMDA receptors and l-arginine/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test

Amino Acids

Volumn 47, Issue 4, 2015, Pages 795-811

  Cunha, Mauricio P ^a   Pazini, Francis L ^a   Ludka, Fabiana K ^a,b   Rosa, Julia M ^a   Oliveira, Ágatha ^a   Budni, Josiane ^a,c   Ramos Hryb, Ana B ^a   Lieberknecht, Vicente ^a   Bettio, Luis E B ^a   Martín De Saavedra, Maria D ^d,e,f   López, Manuela G ^d,e,f   Tasca, Carla I ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO CONTESTADO   (Brazil)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^d INSTITUTO TEÓFILO HERNANDO   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Antidepressant; Cellular viability; Creatine; Nitric Oxide; NMDA; Tail suspension test

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; 7 NITROINDAZOLE; ARCAINE; ARGININE; CREATINE; DEXTRO SERINE; DIZOCILPINE; GLYCINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN SLICE; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; IMMOBILIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL SUSPENSION TEST; ANIMAL; DEPRESSION; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE; CREATINE; DEPRESSION; FEMALE; HINDLIMB SUSPENSION; HUMANS; MICE; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 84925466777     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1910-0     Document Type: Article

References (112)

1. Allen PJ, D'Anci KE, Kanarek RB, Renshaw PF (2010) Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. Neuropsychopharmacology 35:534-546
2. Almeida LS, Salomons GS, Hogenboom F, Jakobs C, Schoffelmeer AN (2006) Exocytotic release of creatine in rat brain. Synapse 60:118-123
3. Andreassen OA, Jenkins BG, Dedeoglu A, Ferrante KL, Bogdanov MB, Kaddurah-Daouk R et al (2001) Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. J Neurochem 77:383-390
4. + toxicity in an organotypic tissue culture system. Cell Transplant 14:537-550
5. Assis LC, Rezin GT, Comim CM, Valvassori SS, Jeremias IC, Zugno AI et al (2009) Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats. Revista Brasileira de Psiquiatria 31:247-252
6. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91-95
7. Baranano DE, Snyder SH (2001) Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci USA 98:10996-11002
8. Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A et al (2005) Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol 252:36-41
9. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351-354
10. Bettio LE, Cunha MP, Budni J, Pazini FL, Oliveira A, Colla AR et al (2012) Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3 K/mTOR pathways. Behav Brain Res 234:137-148
11. Bielenberg GW, Beck T, Sauer D, Burniol M, Krieglstein J (1987) Effects of cerebroprotective agents on cerebral blood flow and on postischemic energy metabolism in the rat brain. J Cereb Blood Flow Metab 7:480-488
12. Brewer GJ, Wallimann TW (2000) Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem 74:1968-1978
13. Brocardo PS, Budni J, Lobato KR, Kaster MP, Rodrigues AL (2008) Antidepressant-like effect of folic acid: involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway. Eur J Pharmacol 598:37-42
14. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8:766-775
15. Carter AJ, Muller RE, Pschorn U, Stransky W (1995) Preincubation with creatine enhances levels of creatine phosphate and prevents anoxic damage in rat hippocampal slices. J Neurochem 64:2691-2699
16. Chen MJ, Russo-Neustadt AA (2007) Nitric oxide signaling participates in norepinephrine-induced activity of neuronal intracellular survival pathways. Life Sci 81:1280-1290
17. Cheng A, Wang S, Cai J, Rao MS, Mattson MP (2003) Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol 258:319-333
18. Choi YB, Lipton SA (2000) Redox modulation of the NMDA receptor. Cell Mol Life Sci 57:1535-1541
19. Constantin-Teodosiu D, Greenhaff PL, Gardiner SM, Randall MD, March JE, Bennett T (1995) Attenuation by creatine of myocardial metabolic stress in Brattleboro rats caused by chronic inhibition of nitric oxide synthase. Br J Pharmacol 116:3288-3292
20. Contestabile A (2000) Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res Rev 32:476-509
21. Contestabile A, Ciani E (2004) Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochem Int 45:903-914
22. Cruz SL, Soberanes-Chávez P, Páez-Martinez N, López-Rubalcava C (2009) Toluene has antidepressant-like actions in two animal models used for the screening of antidepressant drugs. Psychopharmacology 204:279-286
23. Cunha MP, Machado DG, Bettio LE, Capra JC, Rodrigues AL (2008) Interaction of zinc with antidepressants in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 32:1913-1920
24. Cunha MP, Machado DG, Capra JC, Jacinto J, Bettio LE, Rodrigues AL (2012) Antidepressant-like effect of creatine in mice involves dopaminergic activation. J Psychopharmacol 26:1489-1501
25. Cunha MP, Pazini FL, Oliveira A, Bettio LE, Rosa JM, Machado DG et al (2013a) The activation of alpha1-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 44:39-50
26. 1A receptor in the acute antidepressant-like effect of creatine in mice. Brain Res Bull 95:61-69
27. da Silva GD, Matteussi AS, dos Santos AR, Calixto JB, Rodrigues AL (2000) Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. Neuro Rep 11:3699-36702
28. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK et al (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61:450-458
29. de Oliveira RB, Graham B, Howlett MC, Gravina FS, Oliveira MW, Imtiaz MS et al (2010) Ketamine anesthesia helps preserve neuronal viability. J Neurosci Methods 189:230-232
30. Dhir A, Kulkarni SK (2007) Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol 568:177-185
31. Ducray A, Kipfer S, Huber AW, Andres RH, Seiler RW, Schlattner U et al (2006) Creatine and neurotrophin-4/5 promote survival of nitric oxide synthase-expressing interneurons in striatal cultures. Neurosci Lett 395:57-62
32. Duman RS, Li N, Liu RJ, Duric V, Aghajanian G (2012) Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62:35-41
33. Esplugues JV (2002) NO as a signalling molecule in the nervous system. Br J Pharmacol 135:1079-1095
34. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates, 1st edn. Academic Press, San Diego
35. Genius J, Geiger J, Bender A, Moller HJ, Klopstock T, Rujescu D (2012) Creatine protects against excitoxicity in an in vitro model of neurodegeneration. PLoS One 7:e30554
36. Guerrero-Ontiveros ML, Wallimann T (1998) Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol Cell Biochem 184:427-437
37. Haraldseth O, Gronas T, Southon TE, Jynge P, Gisvold SE, Unsgard G (1990) The NMDA antagonist MK-801 improved metabolic recovery after 10 minutes global cerebral ischaemia in rats measured with 31 phosphorous magnetic resonance spectroscopy. Acta Neurochir (Wien) 106:32-36
38. Harkin AJ, Bruce KH, Craft B, Paul IA (1999) Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 372:207-213
39. Harkin A, Connor TJ, Walsh M, St John N, Kelly JP (2003) Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 44:616-623
40. Hashimoto K, Sawa A, Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62:1310-1316
41. Heiberg IL, Wegener G, Rosenberg R (2002) Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav Brain Res 134:479-484
42. Heinzen EL, Pollack GM (2002) Use of an electrochemical nitric oxide sensor to detect neuronal nitric oxide production in conscious, unrestrained rats. J Pharmacol Toxicol Methods 48:139-146
43. Herring NR, Schaefer TL, Tang PH, Skelton MR, Lucot JP, Gudelsky GA et al (2008) Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neurosci 9:49
44. Hevel JM, Marletta MA (1994) Nitric-oxide synthase assays. Methods Enzymol 233:250-258
45. Hua Y, Huang XY, Zhou L, Zhou QG, Hu Y, Luo CX et al (2008) DETA/NONOate, a nitric oxide donor, produces antidepressant effects by promoting hippocampal neurogenesis. Psychopharmacology 200:231-242
46. Iijima M, Fukumoto K, Chaki S (2012) Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test. Behav Brain Res 235(2):287-292
47. Inan SY, Yalcin I, Aksu F (2004) Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol Biochem Behav 77:457-464
48. Joca SR, Guimarães FS (2006) Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology 185:298-305
49. Juravleva E, Barbakadze T, Natsvlishvili N, Kekelidze T, Mikeladze D (2003) Creatine prevents the cytotoxicity of haloperidol by alteration of NO/Ras/NF-κB system. In: Kekelidze T, Holtzman D (eds) Creatine kinase and brain energy metabolism: function and disease. NATO science series: life and behavioral science, vol 343. IOS Press, Amsterdam, pp 113-119
50. Juravleva E, Barbakadze T, Mikeladze D, Kekelidze T (2005) Creatine enhances survival of glutamate-treated neuronal/glial cells, modulates Ras/NF-kappaB signaling, and increases the generation of reactive oxygen species. J Neurosci Res 79:224-230
51. Kaster MP, Rosa AO, Santos AR, Rodrigues AL (2005) Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int J Neuropsychopharmacol 8:601-606
52. Kaster MP, Machado DG, Santos AR (2012) Rodrigues AL (2012) Involvement of NMDA receptors in the antidepressant-like action of adenosine. Pharmacol Rep 64:706-713
53. Kato T, Takahashi S, Shioiri T, Inubushi T (1992) Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 26:223-230
54. 3H] flunitrazepam binding. Society for Neuroscience, San Diego
55. Kim SY, Lee YJ, Kim H, Lee DW, Woo DC, Choi CB et al (2010) Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo (1)H-MRS study at 9.4T. Brain Res 1348:105-113
56. Knox D, Perrine SA, George SA, Galloway MP, Liberzon I (2010) Single prolonged stress decreases glutamate, glutamine, and creatine concentrations in the rat medial prefrontal cortex. Neurosci Lett 480:16-20
57. Koike H, Iijima M, Chaki S (2011) Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res 224:107-111
58. Kondo DG, Sung YH, Hellem TL, Fiedler KK, Shi X, Jeong EK et al (2011) Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study. J Affect Disord 135:354-361
59. Krass M, Wegener G, Vasar E, Volke V (2011) The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis. Behav Brain Res 218:57-63
60. Krystal JH, Sanacora G, Duman RS (2013) Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry 73:1133-1141
61. Laursen SE, Belknap JK (1986) Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16:355-357
62. Lei SZ, Pan ZH, Aggarwal SK, Chen HS, Hartman J, Sucher NJ et al (1992) Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8:1087-1099
63. Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H et al (2011) Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69:754-761
64. Lipton SA, Rayudu PV, Choi YB, Sucher NJ, Chen HS (1998) Redox modulation of the NMDA receptor by NO-related species. Prog Brain Res 118:73-82
65. Lonart G, Wang J, Johnson KM (1992) Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol 220:271-272
66. Lorrain DS, Hull EM (1993) Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuro Rep 5:87-89
67. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
68. Ludka FK, Zomkowski AD, Cunha MP, Dal-Cim T, Zeni AL, Rodrigues AL et al (2013) Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels. Eur Neuropsychopharmacol 23:400-412
69. Lugenbiel P, Sartorius A, Vollmayr B, Schloss P (2010) Creatine transporter expression after antidepressant therapy in rats bred for learned helplessness. World J Biol Psychiatry 11:329-333
70. Lyoo IK, Yoon S, Kim TS, Hwang J, Kim JE, Won W et al (2012) A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. Am J Psychiatry 169:937-945
71. Machado DG, Cunha MP, Neis VB, Balen GO, Colla A, Grando J, Brocardo PS, Bettio LE, Capra JC, Rodrigues AL (2012) Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy. Pharmacol Biochem Behav 103:220-229
72. Mantovani M, Pértile R, Calixto JB, Santos AR, Rodrigues AL (2003) Melatonin exerts antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the l-arginine-nitric oxide pathway. Neurosci Lett 343:1-4
73. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L (1992) Nitric oxide-induced blockade of NMDA receptors. Neuron 8:653-662
74. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927
75. Molz S, Decker H, Dal-Cim T, Cremonez C, Cordova FM, Leal RB et al (2008) Glutamate-induced toxicity in hippocampal slices involves apoptotic features and p38 MAPK signaling. Neurochem Res 33:27-36
76. Moretti M, Freitas AE, Budni J, Fernandes SC, Balen Gde O, Rodrigues AL (2011) Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test. Behav Brain Res 225:328-333
77. Moretti M, Budni J, Ribeiro CM, Rodrigues AL (2012) Involvement of different types of potassium channels in the antidepressant-like effect of ascorbic acid in the mouse tail suspension test. Eur J Pharmacol 687:21-27
78. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
79. Nikonenko I, Boda B, Steen S, Knott G, Welker E, Muller D (2008) PSD-95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling. J Cell Biol 183:1115-1127
80. Nowak G, Ordway GA, Paul IA (1995) Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 675:157-164
81. Oliveira MS, Furian AF, Fighera MR, Fiorenza NG, Ferreira J, Rubin MA et al (2008) The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement. Behav Brain Res 187:200-204
82. Papouin T, Ladepeche L, Ruel J, Sacchi S, Labasque M, Hanini M et al (2012) Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell 150:633-646
83. Parodi M, Rebaudo R, Perasso L, Gandolfo C, Cupello A, Balestrino M (2003) Effects of exogenous creatine on population spike amplitude and on postanoxic hyperexcitability in brain slices. Brain Res 963:197-202
84. Poleszak E, Szewczyk B, Wlaz A, Fidecka S, Wlaz P, Pilc A et al (2008) D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacolog Rep 60:996-1000
85. Raley KM, Lipton P (1990) NMDA receptor activation accelerates ischemic energy depletion in the hippocampal slice and the demonstration of a threshold for ischemic damage to protein synthesis. Neurosci Lett 110:118-123
86. Reus GZ, Stringari RB, Rezin GT, Fraga DB, Daufenbach JF, Scaini G et al (2012) Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain. J Neural Transm 119:481-491
87. Rieger DK, Costa AP, Budni J, Moretti M, Barbosa SG, Nascimento KS, Teixeira EH, Cavada BS, Rodrigues AL, Leal RB (2014) Antidepressant-like effect of Canavalia brasiliensis (ConBr) lectin in mice: evidence for the involvement of the glutamatergic system. Pharmacol Biochem Behav 122:53-60
88. Rodrigues AL, Rosa JM, Gadotti VM, Goulart EC, Santos MM, Silva AV, Sehnem B, Rosa LS, Gonçalves RM, Corrêa R, Santos AR (2005) Antidepressant-like and antinociceptive-like actions of 4-(4′-chlorophenyl)-6-(4′'-methylphenyl)-2-hydrazinepyrimidine Mannich base in mice. Pharmacol Biochem Behav 82:156-162
89. Romero TR, Galdino GS, Silva GC, Resende LC, Perez AC, Cortes SF et al (2011) Ketamine activates the l-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats. Anesth Analg 113:1254-1259
90. Rosa AO, Lin J, Calixto JB, Santos AR, Rodrigues AL (2003) Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behavioral Brain Res 144:87-93
91. Royes LF, Fighera MR, Furian AF, Oliveira MS, Fiorenza NG, Ferreira J et al (2008) Neuromodulatory effect of creatine on extracellular action potentials in rat hippocampus: role of NMDA receptors. Neurochem Int 53:33-37
92. Sanacora G, Zarate CA, Krystal JH, Manji HK (2008) Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7:426-437
93. Satoh S, Murayama T, Nomura Y (1996) Sodium nitroprusside stimulates noradrenaline release from rat hippocampal slices in the presence of dithiothreitol. Brain Res 733:167-174
94. Segieth J, Pearce B, Fowler L, Whitton PS (2001) Regulatory role of nitric oxide over hippocampal 5-HT release in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 363:302-306
95. Sharp JW, Petersen DL, Langford MT (1995) DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock gene in the rat cingulate and retrosplenial cortex. Brain Res 687:114-124
96. Skolnick P (1999) Antidepressants for the new millennium. Eur J Pharmacol 375:31-40
97. Somjen GG, Aitken PG, Balestrino M, Schiff SJ (1987) Uses and abuses of in vitro systems in the study of the pathophysiology of the central nervous system. In: Schurr A, Teyler TJ, Tseng MT (eds) Brain slices in the study of brain damage. Karger, Basel, pp 89-104
98. Spandou E, Karkavelas G, Soubasi V, Avgovstides-Savvopoulou P, Loizidis T, Guiba-Tziampiri O (1999) Effect of ketamine on hypoxic-ischemic brain damage in newborn rats. Brain Res 819:1-7
99. Spiacci A Jr, Kanamaru F, Guimaraes FS, Oliveira RM (2008) Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacol Biochem Behav 88:247-255
100. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367-370
101. Suzuki E, Yagi G, Nakaki T, Kanba S, Asai M (2001) Elevated plasma nitrate levels in depressive states. J Affect Disord 63:221-224
102. Volke V, Wegener G, Bourin M, Vasar E (2003) Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav Brain Res 140:141-147
103. Wlaź P, Kasperek R, Wlaź A, Szumiło M, Wróbel A, Nowak G, Poleszak E (2011) NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice. Pharmacol Rep 63:1526-1532
104. Wu J, Kikuchi T, Wang Y, Sato K, Okumura F (2000) NOx concentrations in the rat hippocampus and striatum have no direct relationship to anaesthesia induced by ketamine. Br J Anaesth 84:183-189
105. Yamamoto M, Koshimura K, Sohmiya M, Murakami Y, Kato Y (2004) Effect of erythropoietin on nitric oxide production in the rat hippocampus using in vivo brain microdialysis. Neuroscience 128:163-168
106. Young LT (2002) Neuroprotective effects of antidepressant and mood stabilizing drugs. J Psychiatry Neurosci 27:8-9
107. 1 dopamine receptor inhibits glutamate-mediated depression induced by chronic unpredictable mild stress in rats. Sheng Li Xue Bao (Acta Physiologica Sinica) 63:333-341
108. Zeni AL, Zomkowski AD, Dal-Cim T, Maraschin M, Rodrigues AL, Tasca CI (2011) Antidepressant-like and neuroprotective effects of Aloysia gratissima: investigation of involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway. J Ethnopharmacol 137:864-874
109. Zomkowski AD, Santos AR, Rodrigues AL (2006) Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. Prog Neuropsychopharmacol Biol Psychiatry 30:1419-1425
110. Zomkowski AD, Engel D, Gabilan NH, Rodrigues AL (2010) Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test. Eur Neuropsychopharmacol 20:793-801
111. Zomkowski AD, Engel D, Cunha MP, Gabilan NH, Rodrigues AL (2012) The role of the NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of duloxetine in the forced swimming test. Pharmacol Biochem Behav 103:408-417
112. Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ (2014) Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur Psychiatry 29:419-423